Background and Objectives: Thyroid ectopy represents a rare disease with an incidence of
0.3–1/100,000. It occurs due to the defective embryological process of the thyroid gland …

Radioactive iodine (RAI) therapy with iodine-131 is performed in select cases of
differentiated thyroid cancer (DTC), typically for remnant ablation, adjuvant therapy, or …

Cellular retinoic acid-binding protein 2 (CRABP2) participates in retinoid partitioning
between different nuclear receptors. Recently, we identified that CRABP2 is one of the …

Context The recommendations for radioactive-iodine treatment (RAIT) in metastatic
differentiated thyroid cancer (DTC) are mostly based in the experience with papillary …

Importance Postoperative radioactive iodine (RAI) remnant ablation for differentiated thyroid
cancer (DTC) facilitates the early detection of recurrence and represents an adjuvant …

The treatment of differentiated thyroid cancer continues to move away from a 'one size fits
all'approach to a process of tailored therapeutic decision-making that incorporates disease …

It remains controversial whether papillary thyroid cancer (PTC) patients with low-to
intermediate-risk disease should receive radioactive iodine (RAI) after total thyroidectomy …

Purpose We performed a systematic review and a meta-analysis to investigate the
successful ablation rate after radioiodine (RAI) administration in patients with differentiated …

Objective The utility of radioiodine (RAI) therapy in intermediate‐risk papillary thyroid
carcinoma (PTC) remains a topic of ongoing discussion. This systematic review and meta …

Context Patients with radioactive iodine (RAI) refractory metastatic differentiated thyroid
cancer (DTC) have poor prognosis. Early identification of RAI refractoriness may improve …